Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus.
about
NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogsHuman Metapneumovirus: lessons learned over the first decadeInitiation and regulation of paramyxovirus transcription and replicationStructure and Functional Analysis of the RNA- and Viral Phosphoprotein-Binding Domain of Respiratory Syncytial Virus M2-1 ProteinCrystal structure of the essential transcription antiterminator M2-1 protein of human respiratory syncytial virus and implications of its phosphorylationDrastic changes in conformational dynamics of the antiterminator M2-1 regulate transcription efficiency in PneumovirinaePotential siRNA Molecules for Nucleoprotein and M2/L Overlapping Region of Respiratory Syncytial Virus: In Silico DesignRequirements for Human Respiratory Syncytial Virus Glycoproteins in Assembly and Egress from Infected Cells.Chimeric bovine respiratory syncytial virus with attachment and fusion glycoproteins replaced by bovine parainfluenza virus type 3 hemagglutinin-neuraminidase and fusion proteinsRespiratory syncytial virus M2-1 protein requires phosphorylation for efficient function and binds viral RNA during infectionRespiratory syncytial virus infection: immune response, immunopathogenesis, and treatmentRecombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzeesModel for polymerase access to the overlapped L gene of respiratory syncytial virusAltered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein.Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation and temperature sensitivity.Transcript initiation and 5'-end modifications are separable events during vesicular stomatitis virus transcription.RhoA interacts with the fusion glycoprotein of respiratory syncytial virus and facilitates virus-induced syncytium formation.Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systemsInactivation of respiratory syncytial virus by zinc finger reactive compounds.Pharmacologic advances in the treatment and prevention of respiratory syncytial virus.The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcriptionIdentification of internal sequences in the 3' leader region of human respiratory syncytial virus that enhance transcription and confer replication processivity.Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles.Three of the four nucleocapsid proteins of Marburg virus, NP, VP35, and L, are sufficient to mediate replication and transcription of Marburg virus-specific monocistronic minigenomes.Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicityChimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccineMutations in the 5' trailer region of a respiratory syncytial virus minigenome which limit RNA replication to one step.Profilin is required for optimal actin-dependent transcription of respiratory syncytial virus genome RNA.Functional analysis of the genomic and antigenomic promoters of human respiratory syncytial virus.Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription.Respiratory syncytial virus can tolerate an intergenic sequence of at least 160 nucleotides with little effect on transcription or replication in vitro and in vivo.Requirement of cysteines and length of the human respiratory syncytial virus M2-1 protein for protein function and virus viabilityGranulocyte-macrophage colony-stimulating factor expressed by recombinant respiratory syncytial virus attenuates viral replication and increases the level of pulmonary antigen-presenting cells.Respiratory syncytial virus infection in adultsRole of protein phosphatase 1 in dephosphorylation of Ebola virus VP30 protein and its targeting for the inhibition of viral transcription.The NS1 protein of human respiratory syncytial virus is a potent inhibitor of minigenome transcription and RNA replicationProtein analysis of purified respiratory syncytial virus particles reveals an important role for heat shock protein 90 in virus particle assembly.Architecture and regulation of negative-strand viral enzymatic machineryRescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30Animal pneumoviruses: molecular genetics and pathogenesis.
P2860
Q24524801-817413F9-FEC5-4DDF-A568-CCA885134365Q26822938-016A6292-BEDB-4237-B940-598BC5FFFD33Q26851684-817A6336-25D6-453E-8785-6B1DEA899D55Q27679531-FC273BD9-890B-472D-ADF7-9DB0E911EFBAQ27681365-887AA46B-7203-4A6E-A47C-D893C2D2142BQ27683836-3BF93A29-6376-4EB7-B9D7-D4D34F0ED941Q28830626-CD341CD2-164B-43DD-83DB-A611AD011120Q30430684-F100F555-39A9-49B8-BA51-4BF68095F287Q30708312-38357790-7183-4683-AAB2-BC87BAE770B6Q31030915-41E28B22-9182-4981-BF0E-110EEB352358Q33588916-51358CE9-46FD-4D17-9856-E2DF0DDED5F9Q33605207-25AA115F-B5DB-4623-8470-F61C45902818Q33639442-B40B5FA0-71F7-4345-B70A-474CD7CA853DQ33639543-06D1020C-EF9E-42A0-8CB8-1022EAA7F835Q33640019-1E84681E-70DB-4775-BDF8-337EF685743AQ33648959-A0EAE706-2C49-491B-9119-0DD6DED26539Q33649134-768F5188-7742-40D9-BB34-45AEE6C1D1EDQ33653597-FB12530A-7F03-4946-932A-3BB8EE15CB94Q33663190-BBB535C5-F1CB-4F88-9824-271D38384843Q33776507-512A1FFF-964C-4542-AB32-8EF0B41F65D5Q33782056-F6EB71D5-1B5A-4A30-B8D7-4695FAD174ABQ33782234-2E1B62F5-CC31-498A-8C34-5DF1D3B09AA0Q33785124-AE97ECA7-DF4F-4A5B-80E5-A16B83339476Q33785253-FB1C3FC9-AFF5-4E15-9F5E-E547C41C3DA2Q33788724-5965EA1A-D3AC-4656-9C90-F2B86FF949CEQ33793103-75BA389A-FF57-4136-A180-737928B3EF14Q33794492-D5B12CD1-DB0A-4A53-A146-B4ACC9850881Q33796013-8531DB9C-95DA-46CA-97E2-E18610D538E2Q33806735-592390E8-A1D2-47CA-B651-1D7E7DA5C446Q33815697-0759A4C0-3F54-4501-8419-C80FAFAC0721Q33826547-F63D4DC3-70C7-4B20-BD1E-7C408BE4428CQ33849620-B81688C6-1982-4430-82B0-0747D2BACBE3Q33870105-8EA7805F-A45D-4431-B111-56F84C543F01Q33961877-7FDDDEEE-F5B2-40AE-B58F-DC5FC5F50D54Q34044597-3CFA243A-DF5B-43B5-901C-80D29EDC2A7FQ34069934-F490ADA7-8E06-40A5-B73D-91731875E85EQ34122163-835E29FD-E28C-4D90-AA13-61C1FFE167BEQ34286309-D7495B38-2DC6-4B52-9565-5854F46455D4Q34301750-BA423481-D3DD-40FE-8A36-0313FA81EE66Q34313560-0A3B9E4E-447D-4FF7-AD8F-D3476FDF16D7
P2860
Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Transcription elongation facto ...... ted negative-strand RNA virus.
@ast
Transcription elongation facto ...... ted negative-strand RNA virus.
@en
type
label
Transcription elongation facto ...... ted negative-strand RNA virus.
@ast
Transcription elongation facto ...... ted negative-strand RNA virus.
@en
prefLabel
Transcription elongation facto ...... ted negative-strand RNA virus.
@ast
Transcription elongation facto ...... ted negative-strand RNA virus.
@en
P2093
P2860
P356
P1476
Transcription elongation facto ...... ted negative-strand RNA virus.
@en
P2093
P2860
P356
10.1073/PNAS.93.1.81
P407
P577
1996-01-01T00:00:00Z